Skip to main content
NCBI home page
Proceedings of the Royal Society of Medicine logoLink to Proceedings of the Royal Society of Medicine
. 1968 Mar;61(3):281–282. doi: 10.1177/003591576806100333

Problems of corticosteroid therapy in the young.

B M Ansell
PMCID: PMC1902275  PMID: 5650991

Full text

PDF
281

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ANDERSON J. P. Prolonged steroid therapy in childhood asthma. Am J Dis Child. 1960 Sep;100:341–352. doi: 10.1001/archpedi.1960.04020040343006. [DOI] [PubMed] [Google Scholar]
  2. BADLEY B. W., ANSELL B. M. Fractures in Still's disease. Ann Rheum Dis. 1960 Jun;19:135–142. doi: 10.1136/ard.19.2.135. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. BARR H. S., WOLFF O. H. Pancreatic necrosis in cortisone-treated children. Lancet. 1957 Apr 20;272(6973):812–815. doi: 10.1016/s0140-6736(57)90974-1. [DOI] [PubMed] [Google Scholar]
  4. BLODGETT F. M., BURGIN L., IEZZONI D., GRIBETZ D., TALBOT N. B. Effects of prolonged cortisone therapy on the statural growth, skeletal maturation and metabolic status of children. N Engl J Med. 1956 Apr 5;254(14):636–641. doi: 10.1056/NEJM195604052541402. [DOI] [PubMed] [Google Scholar]
  5. BYERS R. K., BERGMAN A. B., JOSEPH M. C. Steroid myopathy. Report of five cases occurring during treatment of rheumatic fever. Pediatrics. 1962 Jan;29:26–36. [PubMed] [Google Scholar]
  6. Bacon P. A., Myles A. B., Beardwell C. G., Daly J. R. Corticosteroid withdrawal in rheumatoid arthritis. Lancet. 1966 Oct 29;2(7470):935–937. doi: 10.1016/s0140-6736(66)90537-x. [DOI] [PubMed] [Google Scholar]
  7. FISHER D. A., PANOS T. C., MELBY J. C. INTERMITTENT CORTICOSTEROID THERAPY OF JUVENILE RHEUMATOID ARTHRITIS. Arthritis Rheum. 1964 Aug;7:413–424. doi: 10.1002/art.1780070408. [DOI] [PubMed] [Google Scholar]
  8. Fürst C., Smiley W. K., Ansell B. M. Steroid cataract. Ann Rheum Dis. 1966 Jul;25(4):364–368. doi: 10.1136/ard.25.4.364. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. HARTER J. G., REDDY W. J., THORN G. W. STUDIES ON AN INTERMITTENT CORTICOSTEROID DOSAGE REGIMEN. N Engl J Med. 1963 Sep 19;269:591–596. doi: 10.1056/NEJM196309192691201. [DOI] [PubMed] [Google Scholar]
  10. HEIMANN W. G., FREIBERGER R. H. Avascular necrosis of the femoral and humeral heads after high-dosage corticosteroid therapy. N Engl J Med. 1960 Oct 6;263:672–675. doi: 10.1056/NEJM196010062631404. [DOI] [PubMed] [Google Scholar]
  11. JASIN H. E., FINK C. W., WISE W., ZIFF M. Relationship between urinary hydroxyproline and growth. J Clin Invest. 1962 Oct;41:1928–1935. doi: 10.1172/JCI104650. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. WALKER A. E., ADAMKIEWICZ J. J. PSEUDOTUMOR CEREBRI ASSOCIATED WITH PROLONGED CORTICOSTEROID THERAPY. REPORTS OF FOUR CASES. JAMA. 1964 Jun 1;188:779–784. doi: 10.1001/jama.1964.03060350005001. [DOI] [PubMed] [Google Scholar]
  13. Ward D. J., Hartog M., Ansell B. M. Corticosteroid-induced dwarfism in Still's disease treated with human growth hormone. Clinical and metabolic effects including hydroxyproline excretion in two cases. Ann Rheum Dis. 1966 Sep;25(5):416–421. doi: 10.1136/ard.25.5.416. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Proceedings of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press

RESOURCES